Business Wire
FRANKFURT, Germany & LONDON, February 02, 2023--International medical cannabis company Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN, WKN: A3DG83) today announced that it successfully launched its initial supply to German customers recognizing approximately €1,803,996M 1 in sales of EU GMP high-quality indoor-grown medical cannabis in the last quarter of 2022. On a preliminary, unaudited basis, Akanda has recognized its first material revenues since its inception, validating the Company